Urologic Oncology: Seminars and Original Investigations

Top Research Topics at Urologic Oncology-seminars and Original Investigations?

Urologic Oncology-seminars and Original Investigations investigates studies in Internal medicine, Prostate cancer, Oncology, Bladder cancer and Surgery. It concentrates on Internal medicine topics that focus on Cancer, Renal cell carcinoma, Proportional hazards model, Chemotherapy and Disease. The research on Cancer featured in Urologic Oncology-seminars and Original Investigations combines topics in other fields like Gynecology and Pathology.

Topics in Renal cell carcinoma were tackled in line with various other fields like Carcinoma and Nephrectomy. The studies on Prostate cancer discussed can also contribute to research in the domains of Biopsy, Prostate and Urology. The Urology study tackled is a key component of adjacent topics in the area of Stage (cooking).

The Oncology works featured in Urologic Oncology-seminars and Original Investigations incorporate elements from Clinical trial, Metastasis, Hazard ratio, Radiation therapy and Cohort. The study of Cancer research and how it intertwines with concepts under Cell growth were explored in the presented Bladder cancer research. Nephrology, Perioperative and Retrospective cohort study are all subfields of Surgery research that were featured in it.

• Internal medicine (41.49%)
• Prostate cancer (31.54%)
• Oncology (28.18%)

What are the most cited papers published in the journal?

• Nanoparticles for drug delivery in cancer treatment. (575 citations)
• A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. (531 citations)
• Micro-RNA profiling in kidney and bladder cancers (527 citations)

Research areas of the most cited articles at Urologic Oncology-seminars and Original Investigations:

The journal articles investigate areas of study like Internal medicine, Prostate cancer, Oncology, Bladder cancer and Cancer. The published papers with studies in Internal medicine featured incorporate elements of Gynecology and Surgery. The most cited papers explore issues in Prostate cancer which can be linked to other research areas like Biopsy and Prostate.

What topics the last edition of the journal is best known for?

• Cancer
• Internal medicine
• Gene

The previous edition focused in particular on these issues:

Urologic Oncology-seminars and Original Investigations facilitates discussions on Internal medicine, Prostate cancer, Bladder cancer, Oncology and Cystectomy. Prostate cancer research presented falls under the umbrella topic of Cancer. Some problems in Bladder cancer that were presented in Urologic Oncology-seminars and Original Investigations overlapped with concepts under Stage (cooking), Chemotherapy, Cystoscopy and Urology.

Urology research presented in Urologic Oncology-seminars and Original Investigations encompasses a variety of subjects, including Urothelial carcinoma, Lymphovascular invasion and Retrospective cohort study. The journal explores topics in Oncology which can be helpful for research in disciplines like Immunohistochemistry, Adverse effect, Meta-analysis, Prospective cohort study and Immunotherapy. The journal addresses concerns in Cystectomy which are intertwined with other disciplines, such as Perioperative, Surgery, General surgery and Disease.

The most cited articles from the last journal are:

• Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. (15 citations)
• Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy. (10 citations)
• Prospective Validation of Clinical Usefulness of a Novel mRNA-based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder Cancer. (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Urologic Oncology-seminars and Original Investigations (based on the number of publications) are:

• Shahrokh F. Shariat (122 papers) published 19 papers at the last edition, 1 less than at the previous edition,
• Pierre I. Karakiewicz (88 papers) published 17 papers at the last edition, 6 more than at the previous edition,
• Yair Lotan (84 papers) published 7 papers at the last edition, 3 less than at the previous edition,
• Alberto Briganti (75 papers) published 17 papers at the last edition, 7 more than at the previous edition,
• Ashish M. Kamat (65 papers) published 5 papers at the last edition, 3 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Urologic Oncology-seminars and Original Investigations (based on the number of publications) are:

• University of Texas MD Anderson Cancer Center (178 papers) published 21 papers at the last edition, 6 more than at the previous edition,
• Memorial Sloan Kettering Cancer Center (142 papers) published 9 papers at the last edition, 2 more than at the previous edition,
• Harvard University (125 papers) published 20 papers at the last edition, 11 more than at the previous edition,
• University of Texas Southwestern Medical Center (122 papers) published 15 papers at the last edition the same number as at the previous edition,
• University of Michigan (120 papers) published 11 papers at the last edition, 5 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.07% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 25.06% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.92% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.79% of all publications and 46.23% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Further Study and Growth Opportunities

As Urologic Oncology, Seminars and Original Investigations continues to produce insightful research and explorations within its field, it is essential to highlight other related educational and research opportunities that could contribute to even more innovative studies in the future. One such opportunity is the availability of rigorous nursing programs that provide students and professionals with in-depth knowledge about different facets of health care, including oncology.

For example, the best online nursing programs in Mississippi offer comprehensive course content that is current, relevant, and forward-thinking. These online programs are ideal for individuals looking to deepen their expertise in the medical field while maintaining their current responsibilities. Expanding your knowledge through such programs can greatly enhance your future research work and contributions to Urologic Oncology.

In these programs, students learn about patient care, health assessments, pharmacology, and pathophysiology, among other crucial areas. Such learning can be applied not only in a clinical setting but also in a research context, enriching studies in Urologic Oncology and potentially introducing new areas of investigation.

Education and continuous learning play a crucial part in enhancing the quality of research and scientific discovery. It is hoped that these opportunities will be taken advantage of by many aspiring professionals who seek to leave their mark in the field of Urologic Oncology.